Product Information
LORAZEPAM 1 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0360 per EA under NDC 64980062850. Its NADAC has been published 26 times since Feb 25, 2026.
FDA first approved this application on Jul 24, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980062850
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA218597FDA Approved
7/24/2025
TE Code
AB
On Market Since
7/24/2025
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 1 MG TABLET has been published 26 times since Feb 25, 2026, and over the history we have for it it has declined 5.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0360 per EA |
|---|---|
| All-time high | $0.0381 (Mar 11, 2026) |
| All-time low | $0.0360 (Aug 19, 2026) |
| 52-week high | $0.0381 |
| 52-week low | $0.0360 |
| Median price | $0.0365 |
| Average price | $0.0368 |
| Largest weekly change | -3.1% (Mar 18, 2026) |
| Weeks tracked | 26 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LORAZEPAM 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 1 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0360 per EA (NDC 64980062850), effective Aug 19, 2026.
How has the price of LORAZEPAM 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 1 MG TABLET has declined 5.5%. It has been tracked across 26 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 1 MG TABLET?
Since Feb 25, 2026, the NADAC for LORAZEPAM 1 MG TABLET has ranged from a low of $0.0360 (Aug 19, 2026) to a high of $0.0381 (Mar 11, 2026), with a median of $0.0365 per EA.
Are there cheaper alternatives to LORAZEPAM 1 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LORAZEPAM 1 MG TABLET, is $0.0239 per EA — about 34% below LORAZEPAM 1 MG TABLET.
Who manufactures LORAZEPAM 1 MG TABLET?
LORAZEPAM 1 MG TABLET (NDC 64980062850) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.